Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
about
Successful cognitive aging in persons living with HIV infectionHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Getting to 90-90-90 in paediatric HIV: What is needed?Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohortA Smartphone App to Screen for HIV-Related Neurocognitive ImpairmentCognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.Reaction time variability in HIV-positive individuals.Neurocognitive changes after lung transplantation.Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.Changing scenario of neuropractice.Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere lengthInteractive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease.The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal modelsAntiretroviral Non-Adherence is Associated With a Retrieval Profile of Deficits in Verbal Episodic Memory.Age- and education-matched comparison of aging HIV+ men who have sex with men to general population on common neuropsychological assessments.Relationship of health literacy to intentional and unintentional non-adherence of hospital discharge medications.Increased neurocognitive intra-individual variability is associated with declines in medication adherence in HIV-infected adults.High Concordance between Self-Reported Adherence, Treatment Outcome and Satisfaction with Care Using a Nine-Item Health Questionnaire in InfCareHIVA proposal for quality standards for measuring medication adherence in researchDifferential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults.Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenPrevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and ResearchThe role of prospective memory in medication adherence: a review of an emerging literature.Relationship of Medication Management Test-Revised (MMT-R) performance to neuropsychological functioning and antiretroviral adherence in adults with HIV.Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIVAntiretroviral adherence and the nature of HIV-associated verbal memory impairmentFunctional disability in medication management and driving among individuals with HIV: a 1-year follow-up study.Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.Risk and protective factors for retention in HIV care.Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.Heterogeneity of Neuropsychological Impairment in HIV Infection: Contributions from Mild Cognitive Impairment.A Screening Strategy for HIV-Associated Neurocognitive Disorders That Accurately Identifies Patients Requiring Neurological Review.Mental health challenges among adolescents living with HIVMemory Impairment in HIV-Infected Individuals with Early and Late Initiation of Regular Marijuana Use.Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.Psychosocial Correlates of Medication Adherence among HIV-Positive, Cognitively Impaired Individuals.[HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management].
P2860
Q24631698-2FD5A6E8-2F22-4508-BC6B-C48627A1F52EQ30234305-AFBAAE3D-5553-42A2-AF27-6F4F81A2C23CQ30385352-1EA9D050-D868-4794-8C7D-FE72EC4D41D5Q30485790-E6FC0F84-A0B4-4C29-8BCF-54B13B7C21C1Q33440991-9C715B3A-E730-4C91-8377-07F2C67BE5E7Q33579178-EDC5F456-1939-4C12-A047-9CCEF8963AE7Q33745361-CF425B35-E267-436B-8D14-45BC4C5039DDQ34302244-BC013007-5DA7-49EA-BD9B-7DA9BEEC548CQ34984684-6677AB2E-D786-4F5F-A8B7-53A08F2D4A68Q35009584-8270FD56-910A-471D-B500-CC9B1E6E1323Q35067541-B964AB13-3301-4953-A7B4-130EAB3199BBQ35111027-40655042-D4ED-490A-9EDE-F327FF9FCBE9Q35473482-E8915660-67FB-4E00-A548-A06B0C182E44Q35533693-639EDA18-448C-45B4-AAB0-C2C47D1689BEQ35587341-8FAD102C-F2D9-431A-98E8-24FB91D455CAQ35672135-976C2FA9-7698-4BAB-941A-C0FD7A3ABB80Q35723620-7A641D5B-7B11-4160-81EB-312DF95740B4Q36022011-50A50214-D2A9-46F0-BBF8-26C2E8DB48B0Q36054220-5E4A7D1D-04E4-4655-AA16-C7F0A61D096FQ36210156-1F4B7DE5-AC6A-4984-8A31-7607717B3433Q36291784-977F3BD6-BFD1-4415-BD1D-F56D5C6E7DF2Q36303691-B1D179E6-1EB5-4B73-B14C-ABF3BA263C7BQ36349683-E5EFFA77-88C3-4845-BB0D-438AF37AAF55Q36616443-44BB45D0-84BB-4229-9A35-D0135C6A1BA1Q36616553-68CAE591-9BE0-4ECC-84C2-91D4E213BF6EQ36617630-6DCD27CB-8409-448E-BACE-E1EA5BCE3BF7Q36661109-97A6219E-0BEC-473E-8EF1-FA60D9730932Q36702134-3614F393-80DC-4180-9AC1-5B7EB7B98DDFQ36755399-745C10E1-48FF-4EAC-A7E4-F233C4E2AF61Q37427368-1C818214-6A82-4821-96F2-ECF3FEAB8E23Q37531674-3030528A-3556-4DB6-A34C-EF0367C649F4Q37684714-02DA570C-2505-4A6A-B975-E5E24429CEEEQ38210096-95A57CFE-2D51-46A0-B36B-7511701FD2C0Q38679995-5A5DE3CA-59CF-4BDE-9DE2-33839E34F7EBQ38871573-558F68CD-EE3C-4B0F-BDB7-CB419FFF6E71Q39321831-599E4077-0ECA-4BCA-91CA-C70DD7159B96Q40061133-11A85CF9-62FC-42DE-AE08-AEF0E162AAB9Q40134418-DD347D52-1D81-4E70-B00C-D8FE6C4A7FCEQ41697741-613A70BF-E68F-44D9-80B8-FEC1ED9406A6Q41712400-D1CD81F0-3FEB-44C3-B22F-0040907CAA34
P2860
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@ast
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@en
type
label
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@ast
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@en
prefLabel
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@ast
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@en
P2093
P2860
P1433
P1476
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS.
@en
P2093
Charles H Hinkin
Jessica Foley
Mark L Ettenhofer
Steven A Castellon
P2860
P304
P356
10.1212/WNL.0B013E3181D8C1CA
P407
P577
2010-03-10T00:00:00Z